Approach to the Patient with Persistent Hyperprolactinemia and Negative Sellar Imaging

被引:26
作者
Glezer, Andrea [1 ]
Bronstein, Marcello D. [1 ]
机构
[1] Univ Sao Paulo, Hosp Clin, Unidade Neuroendocrinol, Disciplina Endocrinol & Metabol,Fac Med, BR-05403900 Sao Paulo, Brazil
关键词
CHRONIC-RENAL-FAILURE; DOPAMINE AGONISTS; CLINICAL-PRACTICE; SERUM PROLACTIN; MACROPROLACTIN; DIAGNOSIS; RISK; SUPPRESSION; RECEPTOR; SOCIETY;
D O I
10.1210/jc.2011-2976
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hyperprolactinemia is a common cause of menstrual disturbances affecting young women. There is a diversity of causes, from physiological, such as pregnancy, to pharmacological and pathological, such as hypothyroidism. Renal and hepatic failure, intercostal nerve stimulation by trauma or surgery, prolactinomas, other tumors in the hypothalamus-pituitary region, as well as macroprolactinemia can also be considered. Identifying the correct cause is important to establish the correct treatment. Should all these causes be ruled out and pituitary imaging revealed as negative, idiopathic hyperprolactinemia is therefore diagnosed. In symptomatic patients, treatment with dopaminergic agonists is indicated. As for the asymptomatic hyperprolactinemic individuals, macroprolactinemia should be screened, and once it is detected, there is no need for pituitary imaging study or for dopaminergic agonist use. (J Clin Endocrinol Metab 97: 2211-2216, 2012)
引用
收藏
页码:2211 / 2216
页数:6
相关论文
共 48 条
  • [1] Macroprolactinemia, like hyperprolactinemia, may promote platelet activation
    Anaforoglu, Inan
    Ertorer, Melek Eda
    Kozanoglu, Ilknur
    Unal, Birsel
    Haydardedeoglu, Filiz Eksi
    Bakiner, Okan
    Bozkirli, Emre
    Tutuncu, Neslihan Bascil
    Demirag, Nilgun Guvener
    [J]. ENDOCRINE, 2010, 37 (02) : 294 - 300
  • [2] Polycystic ovary syndrome and hyperprolactinemia are distinct entities
    Barboza Filho, Roberpaulo
    Domingues, Lucilia
    Naves, Luciana
    Ferraz, Elenice
    Alves, Adriana
    Casulari, Luiz Augusto
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (05) : 267 - 272
  • [3] Cancer risk in hyperprolactinemia patients: a population-based cohort study
    Berinder, Katarina
    Akre, Olof
    Granath, Fredrik
    Hulting, Anna-Lena
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (02) : 209 - 215
  • [4] Bronstein M D., 2010, Endocrinology, V6th, P333
  • [5] Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
    Casanueva, Felipe F.
    Molitch, Mark E.
    Schlechte, Janet A.
    Abs, Roger
    Bonert, Vivien
    Bronstein, Marcello D.
    Brue, Thierry
    Cappabianca, Paolo
    Colao, Annamaria
    Fahlbusch, Rudolf
    Fideleff, Hugo
    Hadani, Moshe
    Kelly, Paul
    Kleinberg, David
    Laws, Edward
    Marek, Josef
    Scanlon, Maurice
    Sobrinho, Luis G.
    Wass, John A. H.
    Giustina, Andrea
    [J]. CLINICAL ENDOCRINOLOGY, 2006, 65 (02) : 265 - 273
  • [6] Medical treatment of prolactinomas
    Colao, Annamaria
    Savastano, Silvia
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (05) : 267 - 278
  • [7] Etiological diagnosis of hyperprolactinemia
    Cortet-Rudelli, C.
    Sapin, R.
    Bonneville, J.-F.
    Brue, T.
    [J]. ANNALES D ENDOCRINOLOGIE, 2007, 68 (2-3) : 98 - 105
  • [8] Antipituitary antibodies in idiopathic hyperprolactinemic patients
    De Bellis, Annamaria
    Colao, Annamaria
    Pivonello, Rosario
    Savoia, Antonella
    Battaglia, Marina
    Ruocco, Giuseppe
    Tirelli, Gilda
    Lombardi, Gaetano
    Bellastella, Antonio
    Bizzarro, Antonio
    [J]. AUTOIMMUNITY, PT C: THE MOSAIC OF AUTOIMMUNITY, 2007, 1107 : 129 - 135
  • [9] Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
    Dekkers, Olaf M.
    Lagro, Joep
    Burman, Pia
    Jorgensen, Jens Otto
    Romijn, Johannes A.
    Pereira, Alberto M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01) : 43 - 51
  • [10] FALASCHI P, 1980, OBSTET GYNECOL, V55, P579